Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Heron Therapeutics Inc (HRTX) – Heron Therapeutics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Heron Therapeutics (HRTX) trades at $0.8455, down 1.62% on the day, with a bearish technical signal despite unanimous analyst buy ratings. The company reported Q1 2026 revenue of $151M with a net loss of $31M, missing EPS expectations. While the acute care franchise shows growth, profitability remains challenged with a negative net income margin of -20.53% and elevated EV/EBITDA of 34.03. Management reaffirmed full-year 2026 guidance for net revenue of $173-$183M and positive adjusted EBITDA of $10-$20M.
The investment case hinges on execution toward profitability. The 100% analyst buy consensus reflects optimism around the revenue guidance and path to adjusted EBITDA positivity. Key risks include consistent earnings misses, high valuation multiples relative to current losses, and the need to convert top-line growth into sustainable bottom-line results. Cash flow trends show improvement, with net cash flow projected to rise from $3M in 2025 to $7M in 2026.
Read full analysis

Key Stats

  • Market Cap
    $160.79M
  • Sector
    Health
  • 3M Drawdown
    -37.84%
  • Enterprise Value
    $258.69M
  • Dividend Yield
    -
  • Trading Activity
    31% Buy | 69% Sell
  • Typical Hold Time
    16 days
$0.86
52W Low: $0.75
30 Mar 2026
52W High: $2.23
09 Jul 2025

Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $160.79M, with an enterprise value of $258.69M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.75 and a high of $2.23, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -37.84%, reflecting recent price volatility. On average, investors hold Heron Therapeutics Inc for approximately 16 days, indicating typical investor behavior on the platform.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $160.79M
  • Sector
    Health
  • 3M Drawdown
    -37.84%
  • Enterprise Value
    $258.69M
  • Dividend Yield
    -
  • Trading Activity
    31% Buy | 69% Sell
  • Typical Hold Time
    16 days
$0.86
52W Low: $0.75
30 Mar 2026
52W High: $2.23
09 Jul 2025

Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $160.79M, with an enterprise value of $258.69M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.75 and a high of $2.23, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -37.84%, reflecting recent price volatility. On average, investors hold Heron Therapeutics Inc for approximately 16 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!